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The Chosen ONES
Awards Fund Young
Investigators
A major goal of the 2006 NIEHS
Strategic Plan encompasses the institute’s
desire to “recruit and train the next gener-
ation of environmental health scientists.”
To begin to achieve that goal, the NIEHS
has unveiled a new annual grants program
called the Outstanding New Environ-
mental Scientist (ONES) Award. The
five-year grants are designed to identify,
encourage, inspire, and support outstand-
ing investigators early in their careers,
who have not yet received their first R01
grant. The first ONES grants, totaling
$3.6 million, were awarded in September
2006 to eight promising young scientists
chosen from more than 70 applicants
through a rigorous application, review,
and interview process.
The program is the brainchild of
NIEHS director David Schwartz, who has
been concerned for some time about the
loss of promising young scientific talent
from the field for lack of support. “As a
faculty member at Duke,” he says, “I
found that the individuals who were par-
ticularly vulnerable in terms of their
career development were those at that
transitional stage between mentored and
independent research, and that many very
bright, creative people simply were not
supported in ways that enhanced their
career development.”
Schwartz says the awards are also
intended to help attract innovative young
investigators to the NIEHS and the envi-
ronmental health sciences, as well as to
support the institutions that are helping
new scientists develop their careers. The
program’s long-term impact on the field,
in terms of both the science and the scien-
tists, could be significant. “These individ-
uals represent very promising early career
trajectories that are likely to have a sub-
stantial effect on environmental health
sciences, and hopefully will evolve into
the leaders in the field in the future,” says
Schwartz. 
To ease that tricky early-career transi-
tion, ONES grantees are encouraged to
establish and meet annually with an advi-
sory committee comprising senior experts
in their disciplines. According to Pat
Mastin, chief of the NIEHS Cellular,
Organ, and Systems Pathobiology Branch,
who helped coordinate the initial ONES
process, the grants represent a hybrid
between mentored career development
awards and independent R01 grants. “We
think the young investigators should con-
tinue to be mentored,” Mastin says. “So
we encouraged them to identify not a spe-
cific mentor, but an advisory committee,
to give not only scientific advice but also
career path advice.”
The grantees recognize and appreciate
the value of this hybrid approach to men-
toring. “It gives us access to people we
wouldn’t normally be interacting with,”
says ONES grantee Thomas Begley, an
assistant professor in the Department of
Biomedical Sciences at the University at
Albany State University of New York.
“Having a mechanism to ensure that will
promote good science on my end, and
also will help me network with others in
the field.” 
Grantee Patricia Opresko, an assistant
professor in the Department of Envi-
ronmental and Occupational Health at
the University of Pittsburgh, agrees. “The
grant has funds that will allow the four
investigators on my advisory committee to
come to Pittsburgh and meet with me
once a year to focus on my project and
offer their ideas, insight, input, and criti-
cisms,” she says. “It adds an additional
layer of mentoring that is really critical for
a young investigator’s development.” 
Investing in the Future
Funding included in the grants is front-
loaded with additional monies in the early
years. This allows the investigators to
expand and accelerate their research pro-
grams by purchasing equipment, adding
personnel, and participating in specialized
training activities and course work. For
each of the five years, the researcher can
receive up to $250,000 in direct costs. An
additional $150,000 per year is provided
in the first two years, with $25,000 per
year added in years three through five. 
Grantees are expected to devote up to
80% of their time to their research pro-
jects in the first two years. This scenario is
designed to encourage the scientists to
eventually pursue other grant opportuni-
ties, gradually becoming more entrepre-
neurial, more collaborative, and more
independent principal investigators.
Not surprisingly, the grantees expect
the protected time and generous funding
to benefit their research agendas and
careers tremendously. “This award allows
me to get some equipment into the lab
that I would have had trouble getting on
my own, and to set up what I term ‘mini-
sabbaticals,’ where I can go and seek the
additional training that I need to suc-
ceed,” says Stephania Cormier, an assis-
tant professor of biological sciences at
Louisiana State University. 
“Being a physician-scientist, this will
give me protected time to focus on
research, as opposed to clinical work,”
says Gökhan Mutlu, an assistant profes-
sor in the Division of Pulmonary and
Critical Care Medicine at Northwestern
University. 
Michael Borchers, a research assistant
professor in the Department of Internal
Medicine at the University of Cincinnati,
is excited that the grant will allow him to
expand the scope of his study. “This is
going to take me from being a hammer to
a jackhammer in terms of trying to bust
this research question up,” he says. “The
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ONES awardees. (left to right) Gökhan Mutlu, Stephania Cormier, Patricia Opresko, Sven-Eric
Jordt, Michael Borchers, Donna Zhang, Michelle Bell, Thomas Begleyequipment I’m getting is going to add to
the validity of my conclusions and the
strength and speed with which I can
attack the question.” 
Donna Zhang, an assistant professor in
the Department of Pharmacology and
Toxicology at the University of Arizona,
sees both short- and long-term rewards.
“With this grant, I will be able to do
benchtop research, plus I’m going to hire
more graduate students and postdocs, so it
will definitely move the research faster, to
get publication faster and to test the
hypothesis faster,” she says. “And I think
it will speed up my tenure and my growth
in academics.”
Each of the eight inaugural ONES
awardees is poised to make significant
contributions to knowledge in the envi-
ronmental health sciences, with potential
therapeutic, preventive, or policy transla-
tional applications. Their timelines may
vary considerably, but all are confident
that the ONES grant will accelerate the
progress of their research and the realiza-
tion of actionable results. 
ONES Research Thumbnails
Begley is exploring cell signaling pathways
that contribute to DNA repair when dam-
age results from exposures to environmental
toxicants. His group has identified a path-
way that may govern the production of
damage response proteins controlled by
multiple tRNA methyltransferases. They
will use yeast, human, and mouse cell lines
as models to explore the activity of the path-
way in response to environmental insults. 
Ultimately, the aim is to determine
how RNA-based signals coordinate DNA
damage response pathways. “Under-
standing all of the different cellular com-
ponents that work in response to exposures
would be important for predicting individ-
ual susceptibility to environmentally
induced diseases,” says Begley. “Also, if we
can have a better understanding of stress
response pathways, they have the potential
to be exploited for clinical purposes.”
The ONES award will allow Michelle
Bell, an assistant professor of environmen-
tal health at the Yale School of Forestry &
Environmental Studies, to substantially
expand her investigation of the mortality
and morbidity effects of tropospheric
ozone. With a background in both envi-
ronmental engineering and epidemiology,
she is the sole ONES grantee pursuing an
epidemiological project. She plans to use
the funding to add to her staff and com-
puter equipment, as well as to take courses
and establish collaborations. 
“Instead of just looking at whether
there’s a link between ozone and mortality,
I will investigate by how far deaths are
advanced from ozone, which is a very dif-
ferent public health question if it’s just a
few days versus . . . a few months or even
years,” says Bell. She will also investigate
the effects of exposure to complex mix-
tures of air pollutants, which more closely
mirrors the actual environment in which
people are simultaneously exposed to
many different agents. “I think this work
will be very interesting to policy makers,
because it’s trying to look at situations in
the real world,” she says. “My work is
population epidemiology–based; it’s not
hypothetical.” 
Borchers’ work involves exposures to
air pollutants that activate the innate
immune system, releasing pulmonary lym-
phocytes via some of the same mecha-
nisms that release them when the lung is
exposed to biological pathogens. Although
the molecular pathway involved is appar-
ently conserved, it is presently unclear why
the system responds the way it does to
toxicants. Borchers is investigating the
potential role of this phenomenon in
chronic obstructive pulmonary disease
(COPD), looking at a pathway that
involves NKG2D receptor activation in
pulmonary epithelial cells.
“If [the receptor] is activated by a toxi-
cant, it’s unnecessarily causing the
immune system to do something disrup-
tive,” he explains. “This hyperresponse
may contribute to the pathophysiology of
chronic airway diseases, especially in
genetically susceptible populations.”
Borchers says the genes he is studying
relative to this phenomenon are highly
polymorphic. “I want to study the genetic
variability of these pathways, to see whether
that variability contributes to susceptibility
to COPD,” he says. “Out of one hundred
people who have a hyperactive immune sys-
tem, how many of them are hyperreactive
due to the polymorphisms in genes associ-
ated with activation of the immune system?
If you identify a subpopulation, then per-
haps you could have directed therapeutics.”
Cormier is seeking to determine
whether exposure during early neonatal
life to ultrafine particulate matter (PM0.1)
leads to predisposition to, development
of, or exacerbation of allergic respiratory
disease in adults. PM0.1 is typically pro-
duced from incineration of hazardous
wastes. As she explains the concept, incin-
eration sites filter PM2.5 and larger parti-
cles, and there are regulatory restraints on
how much PM2.5 can be in the air. But
research has shown that up to 70% of
PM2.5 is composed of PM0.1 and smaller,
and the EPA does not monitor or regulate
these ultrafine particles. 
PM2.5 has been implicated in a variety
of adverse health effects; there are spikes
in cardiovascular and respiratory events in
areas where PM2.5 levels exceed EPA stan-
dards. There is some suspicion that
because the majority of these particles are
ultrafine, they may be causing the acute
health effects seen in emergency rooms.
By studying acute exposures in neonates,
Cormier hopes to shed light on the poten-
tial physiologic underpinnings of expo-
sure-related adverse events.
She is also looking at how ultrafine
particles affect the still-developing lung to
determine whether an acute exposure in
the neonate predisposes the child to devel-
op a chronic disease state later in life.
“Two things could be happening,” says
Cormier. “The ultrafine particles could be
changing structure—and we have some
evidence that the exposure is actually
changing genes that control lung struc-
ture—or the particles could be changing
the immune response, so that you are
more prone to an allergic-type response.” 
Cormier has previously studied these
issues from an infectious disease point of
view, looking at how respiratory syncytial
virus exposure in neonatal animals perma-
nently changes the lung and the immune
system. In her ONES work, she will be
using some of these same techniques to
see if oxidative stress produced by pollu-
tant particles causes these long-term
changes. “The outcome of these studies
could have important implications for
both public health and environmental
policy,” she says.
Sven-Eric Jordt, an assistant professor
in the Department of Pharmacology at the
Yale University School of Medicine,
comes to environmental health science
from the pain research field. For his
ONES project, he will study the function
of sensory neurons in the periphery of the
body related to exposure to environmental
chemical irritants. This will build upon
his previous work on the effects of noxious
natural products on sensory neurons and
their receptors. 
Jordt has found that some of those
receptors are also activated by environ-
mental irritants, and that the response is
likely to involve the ion channel TRPA1,
which is expressed exclusively in sensory
fibers that are also sensitive to capsaicin,
an irritant derived from chili peppers.
“We will try to identify novel receptors
for environmental irritants, how these irri-
tants interact with the receptors, and how
they are activated and regulated, especially
in the background of inflammatory dis-
ease and asthma, chronic cough, or aller-
gic conditions,” he says. 
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immune system in hypersensitivity
responses has been well studied in the
environmental health sciences, sensory
neuroscience is an aspect of the human
response to environmental toxicants that
has been mostly neglected. He points out
that the receptors involved have been
intensely studied in the pain research and
pharmaceutical arenas to help develop
anti-inflammatory agents and analgesics.
“We imagine that some of these agents
may also reduce irritation by chemical irri-
tants, or reduce hypersensitivity in patients
with allergy or asthma, for example,” says
Jordt. “So we can basically translate some
of the results coming from pain pharma-
cology or irritant pharmacology into clini-
cal applications in the environmental
health sciences.”
Mutlu’s research interest is in how the
responses of the alveolar epithelium to air
pollution can lead to adverse cardiovascu-
lar effects. He hypothesizes that pul-
monary exposure to ambient PM may
cause the blood to thicken, leading to
thrombosis, or clot formation, and that
this may be one of the mechanisms to
explain how air pollution contributes to
heart attacks and strokes. His ONES pro-
ject will elucidate the physiological mecha-
nisms involved in the hypercoagulation
response to PM exposure.
Mutlu’s previous experiments have
suggested that this response may involve
increased production of the inflammatory
mediator interleukin-6 (IL-6). In knockout
mice lacking IL-6, exposure to PM did not
elicit hypercoagulation. “We can also block
it by pretreating the animals with beta
blockers, which are well known and com-
monly used medications for heart disease,”
says Mutlu. 
Although the phenomenon does not
cause disease, Mutlu explains that it accen-
tuates risk of a cardiovascular event in an
individual with underlying heart disease or
tendency toward stroke. “We will look at
the applicability of our findings to human
disease,” he says. “If we can confirm our
findings, the use of beta blockers may pre-
vent some of the cardiovascular mortality
associated with particulate matter.”
Opresko is investigating the mecha-
nisms of genomic instability associated
with aging and aging-related diseases, par-
ticularly what happens to the telomere
structures at the end of the chromosome,
which in most human somatic cells dwin-
dle with age. Epidemiological studies have
shown that oxidative stress associated with
inflammatory diseases, obesity, and smok-
ing can also contribute to an accelerated
rate of telomere loss. On a DNA sequence
level, the sequences that occur at telomeric
ends are rich in guanine runs, and are par-
ticularly prone to oxidation. 
Environmental metals are an impor-
tant source of oxidative stress, and
Opresko plans to explore the association
between exposure to metals and accelerat-
ed telomere shortening. “We’re particular-
ly interested in hexavalent chromium,” she
says. “This metal is an environmental car-
cinogen that causes respiratory cancers
and respiratory disease due to its route of
exposure, and is an occupational hazard
associated with the welding industry.”
Opresko explains that hexavalent
chromium has been found to induce differ-
ent types of DNA adducts, chromium
adducts, cross-linked adducts, single-strand
breaks, and double-strand breaks, particu-
larly in guanine runs. So in addition to
causing oxidative stress, it is likely that
hexavalent chromium also induces direct
DNA damage in these sequences. “We
think that hexavalent chromium is an
excellent agent and probe to determine the
consequences of environmental DNA dam-
age on telomeric integrity, and also to help
us understand cellular pathways that repair
telomeric damage,” says Opresko. “By
understanding these mechanisms, we might
be able to design intervention therapies that
can help preserve our telomeric ends, and
delay the onset of some of the aging-related
diseases that are associated with telomere
dysfunction.” Such diseases include cancer,
macular degeneration, and osteoporosis. 
Zhang is studying a chemoprotective
cellular pathway called the antioxidant
response element–Nrf2–Keap1 signaling
pathway, which can be activated by dietary
compounds. She hypothesizes that activa-
tion of the pathway acts as an endogenous
protective system against arsenic-induced
toxicity and carcinogenicity.
Drinking water contaminated with
arsenic, a known carcinogen, is a world-
wide public health problem. However,
arsenic is not a mutagen, but induces
malignant transformation possibly through
an epigenetic or cell signaling mechanism,
causing cellular damage through generation
of reactive oxygen species. “By understand-
ing the pathway, we can boost people’s
antioxidant responses, which could have a
broad impact on public health worldwide,”
says Zhang.
The pathway itself is mainly controlled
by the transcription factor Nrf2. Recent
findings have shown that Nrf2 knockout
mice have displayed increased sensitivity to
chemical toxicants and carcinogens, and
are resistant to the protective actions of
chemoprotective compounds. In her
ONES project, Zhang will seek to elucidate
the mechanism of Nrf2 activation to pro-
tect against arsenic-induced toxicity and
tumorigenicity.
Zhang’s work could also lead to the
design of a small molecule pharmaceutical
that would up-regulate the antioxidant
pathway. “But,” she says, “for people in
developing countries where arsenic in
drinking water is such a problem and
where a pharmaceutical drug is too expen-
sive for them, it will be much cheaper and
more readily available if we identify natu-
rally occurring protective compounds in
vegetables or plants.” In short, she advises,
“Eat your broccoli!” –Ernie Hood
A New Tool to
Trace Genetic
Susceptibility
Just like individual people, various mouse
strains come in different sizes and colors,
and with different predispositions to dis-
ease. Since more than 99% of human
genes can be matched to analogous mouse
genes that have similar functions, scien-
tists often study mouse models to better
understand human disease. It’s already
well known which strains of mice are
genetically at greater risk for certain dis-
eases. But what isn’t so clear is which
small genetic variations, or single-
nucleotide polymorphisms (SNPs), lead
to these differences. 
SNPs aren’t large mutations but normal
variations of one letter of the genetic code.
For example, a sequence that reads AATTC-
CG in one strain of mouse may show up as
AATACCG in another. Now Scientists who
study mice as models for human disease
have a new tool to help them more quickly
home in on the SNPs that matter when it
comes to disease susceptibility. With the
completion of the NIEHS-funded
Resequencing and SNP Discovery Project,
announced in October 2006, researchers
now have free access to a data set of 8.3. mil-
lion SNPs housed on the National Center
for Biotechnology Information website at
http://www.ncbi.nlm.nih.gov/SNP/. 
Researchers at Perlegen Sciences, under
contract to the National Toxicology
Program, resequenced the genomic DNA of
15 genetically diverse research mouse strains
by comparing the sequences to a reference
mouse strain (the first mouse strain to have
its DNA completely sequenced to very high
accuracy). Kelly Frazer, principal investiga-
tor of the project and vice president of
genomics at Perlegen Sciences, says, “We
take these pieces of DNA and align them to
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ferences.” To do that, the scientists used the
same high-density oligonucleotide array
technology that was used to discover com-
mon DNA variations in the human
genome.
The completion of the project pro-
vides a powerful tool; many discoveries
should come when scientists use it.
“We’re looking forward to researchers
using these . . . SNPs in comparative stud-
ies of the different mice strains that are
physiologically and physically well charac-
terized,” Frazer says. 
David Threadgill, an associate profes-
sor of genetics at the University of North
Carolina at Chapel Hill, says the data set
was critical in recent studies that revealed
genes that may contribute to human sus-
ceptibility to liver damage from aceta-
minophen. His work, currently under
review for publication, was inspired by a
paper published 5 July 2006 in JAMA
showing that a subset of the study partici-
pants showed greater susceptibility to liver
damage from taking recommended doses
of acetaminophen. “However, clearly it’s
unethical to go in and treat thousands of
individuals to try to find the underlying
genetic causes of that,” Threadgill says. 
Instead, Threadgill and colleagues
used the SNP maps of the 15 mouse
strains to identify genetic variance
between strains of mice that differed in
liver toxicity due to acetaminophen. They
then tested two candidate genes in a small
human study. They found that variance in
the two candidate genes correctly predict-
ed the patients who showed high levels of
serum markers of liver toxicity after taking
the maximum recommended dose of
acetaminophen for several days. “Without
these detailed SNP maps, we would not
have been able to have very quickly done
that translational test, which we were able
to do just in a matter of months,”
Threadgill says.
NIEHS director David Schwartz says
the conclusion of the Resequencing and
SNP Discovery Project represents a mile-
stone that builds on fundamental accom-
plishments such as the 2003 completion of
the human genome sequence. “This accom-
plishment provides the tools to discover
genes in mice that play critical roles in the
response to environmental toxicants and
the development of disease,” Schwartz says.
“The environmentally responsive genes and
the disease-related genes in mice are very
likely to be important in human disease.
This development can be used to identify
those at risk, prevent the development of
disease, and also identify promising new
forms of treatment.” –Angela Spivey
Environmental Health Perspectives • VOLUME 115 | NUMBER 1 | January 2007 A 27
NIEHS News
J
a
i
m
i
e
 
D
u
p
l
a
s
s
/
S
h
u
t
t
e
r
s
t
o
c
k
Headliners Immunity
NIEHS-Supported Research
PCB Exposure Affects Antibody Response in Vaccinated Children
Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jørgensen E. 2006. Reduced anti-
body responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS
Med 3(8):e311. 
Although children are known to display varied antibody responses to vaccina-
tion, little is known about the causes of these variations. One possibility is that
persistent organochlorine pollutants such as polychlorinated biphenyls (PCBs)
elicit immunotoxic effects that influence the production of specific antibodies.
In this report, NIEHS grantee Philippe Grandjean of the Harvard School of
Public Health and his colleagues confirm an association between increased PCB
exposure and decreased antibody production in vaccinated children.
The researchers looked at two birth cohorts of generally healthy children
(119 children at age 18 months and 129 at age 7 years) living in the Faroe
Islands of the North Atlantic, where the traditional diet includes whale blub-
ber that may be contaminated with PCBs. The children were examined after
receiving routine childhood vaccinations against tetanus and diphtheria. The
researchers determined the children’s exposure to PCBs by measuring PCB
concentrations in their mothers’ blood during pregnancy and milk soon after
birth, and in the children’s own blood at the time of the study. 
The researchers used standard regression analysis techniques to deter-
mine the effects of PCB exposure on the production of diphtheria and
tetanus antibodies in the children. They found that for each doubling of PCB
exposure, diphtheria antibody response decreased by 24% in the 18-month-
old children. They also saw a 16% reduction of the tetanus antibody response
with each doubling of exposure in the older children. Both prenatal and post-
natal exposure seemed to significantly affect antibody concentrations.
Although most of the children’s antibody concentrations were well within the
range considered necessary to protect against tetanus and diphtheria, the
researchers noted diphtheria antibody concentrations below the acceptable
limit for long-term protection in 26 of the 7-year-olds two years after receiv-
ing a booster vaccination.
Limitations to the study included the small number of children in the
two cohorts and the possibility of exposure to other seafood contaminants,
such as p,p´-DDE. However, the authors say the findings demonstrate evi-
dence of pollutant influences on reduced antibody production after routine
childhood vaccination, which could lower a child’s protection against infec-
tious diseases. –Tanya TillettBEYOND THE BENCH
Prevention Pays 
for Farmworkers
Many agricultural growers use pesticides
to protect crops and ensure satisfactory
yields. Although the United States has
some of the strictest laws governing pesti-
cide applications and re-entry into fields
after application, a number of studies have
demonstrated that farmworkers are still
being exposed to pesticides in the fields and
that they may take the chemicals home on
their skin and clothing, potentially expos-
ing their families. This risk prompted the
University of California, Berkeley, Center
for Children’s Environmental Health
Research to join with community partners
Clinica de Salud del Valle de Salinas, the
California Rural Legal Assistance Program,
and the Central Coast Grower–Shipper
Association to conduct a study on ways to
alleviate this hazard. The community-based
participatory research study employed a
field-based technical intervention designed
to reduce farmworker exposure to pesti-
cides and the potential for take-home pesti-
cide exposures. 
The partnership, through its Center for
Health Assessment of Mothers and
Children of Salinas (CHAMACOS),
recruited 130 study participants working at
two Monterey County strawberry farms
during the summer of 2003. Then they
initiated preventive measures to decrease
direct exposure to malathion (a pesticide
commonly used in strawberry fields) and
lessen the amount of pesticide residues
workers carried home on clothing, skin,
and shoes.
“The agricultural work environment is
very complex, with changes in weather para-
meters, soil moisture, crops, tasks, and other
factors occurring over short time frames,”
says Asa Bradman, CHAMACOS associate
director. “We focused on strawberry har-
vesting to ensure that the crop and task
could be held constant. We chose to study
malathion because it can be [simultaneous-
ly] measured in . . . foliar residue samples,
in personal samples such as hand rinse and
clothing patch samples, and in urine as the
metabolite malathion dicarboxylic acid.”
The study began with surveys, urine
sampling, and foliage
sampling during a
pre-intervention
process to determine
the farmworkers’ ini-
tial exposure levels.
Intervention activities
began a month later.
The team provided
protective clothing
(lightweight coveralls
and disposable gloves),
educational sessions
at the worksite on
exposure prevention,
shoe boxes and laundry bags to store work
clothing and shoes, and a field station with
warm water and soap for handwashing.
Post-intervention data collection in October
of the same year included surveys, urine
sampling, hand rinse sampling, clothing
patch sampling, and foliage sampling.
The initial feedback from the partici-
pants indicated that the intervention strate-
gies could lower overall exposure if used on
a regular basis. One of the solutions, the use
of a hot water heater in the field to provide
warm water for handwashing, had never been
tried before. During the pre-intervention
phase, many farmworkers revealed that they
had previously avoided washing their hands
while picking strawberries because they
believed that washing with cold water,
which was all that was available, could cause
arthritis. The availability of the warm water
led to more handwashing and thus less pes-
ticide residue on hands. 
The protective clothing and storage for
work clothes and shoes also proved helpful
to the workers in limiting pesticide expo-
sure. Alicia Salvatore, CHAMACOS
intervention study coordinator, says,
“Many [farmworkers] reported that they
experienced fewer dermal rashes when
they used gloves, and almost all workers
noticed a marked change in amount of
dirt that they carried home at the end of
the day on the clothing that they wore
under their coveralls. Almost all workers
who participated were interested in con-
tinuing these behaviors.”
Brenda Eskenazi, CHAMACOS direc-
tor and principal investigator of the pro-
ject, sees a necessity and potential for
these types of measures, and says the part-
nership will continue to advance that
cause. “We believe it is important to
develop sustainable interventions—that
is, interventions that are cheap and effec-
tive in reducing exposure to pesticides,”
she says. “This intervention . . . is an
important first step in this direction.”
Bradman says the growers who partici-
pated in the intervention were supportive of
the project and plan to continue to use the
preventive measures to the fullest extent
possible. He adds that the community part-
ners in CHAMACOS are presenting their
findings to other growers and agricultural
organizations, as well as preparing reports
for publication. –Tanya Tillett
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Field work. CHAMACOS researchers collected samples in the field including clothing patches
(top) and urine samples (above) to assess pesticide exposures of agricultural workers.